Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 13 Weeks

19-Jan-17 - 19-Apr-17
Buy Ratio:30%

Down

# Net Buyers:62
# Net Sellers:142

Previous 13 Weeks

20-Oct-16 - 18-Jan-17
Buy Ratio:36%
# Net Buyers:81
# Net Sellers:144
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Colucid Pharmaceuticals, Inc.$716.39M$716.97M  
Regeneron Pharmaceuticals Inc($400.00K)$76.79M  
Biomarin Pharmaceutical Inc($14.03M)$30.01M  
Exact Sciences Corp($1.67M)$23.95M  
Acceleron Pharma Inc--$21.88M  
New Net Buyers
CompanyNet Buy AmountChange
Colucid Pharmaceuticals, Inc.$716.39M$716.97M  
Merck & Co., Inc.$3.40M$19.12M  
Bellicum Pharmaceuticals, Inc$1.62M$3.29M  
Agenus Inc$744.97K$1.66M  
Cumberland Pharmaceuticals Inc$680.86K$770.21K  
Largest Negative Net Change
CompanyNet Buy AmountChange
Mylan N.V.($1.83B)($1.83B)  
Valeant Pharmaceuticals International, Inc.($166.32M)($115.02M)  
Seattle Genetics Inc /wa($3.41M)($88.20M)  
Pfizer Inc($56.92M)($55.19M)  
Esperion Therapeutics, Inc.($49.31M)($49.36M)  
New Net Sellers
CompanyNet Buy AmountChange
Seattle Genetics Inc /wa($3.41M)($88.20M)  
Esperion Therapeutics, Inc.($49.31M)($49.36M)  
Johnson & Johnson($37.75M)($37.85M)  
Abbott Laboratories($15.99M)($32.29M)  
Medicines Co /de($5.83M)($29.53M)